News

Latest news

Hide mandatory notifications of trade

Offer for shares in Bionor Immuno AS

20.01.2010 - With reference to the release 12 January and the offer document for offer to shareholders in Bionor Immuno, Nutri Pharma announces that it has receivedacceptances for 96,54% of the shares in Bionor Immuno

This information is subject of the disclosure requirements acc. to §5-12 vphl
(Norwegian Securities Trading Act)
With reference to the release 12 January and the offer document for offer to
shareholders in Bionor Immuno, Nutri Pharma announces that it has received
acceptances for 96,54% of the  shares in Bionor Immuno. The offer is still
subject to the conditions referred to in the offer. "